Oncolytic Transcriptionally Retargeted Adenovirus Expressing Nitroreductase in Combination with Antiangiogenic Drug RAD001

被引：0
|
作者：
Lukashev, Alexander N. [1 ]
Homicsko, Krizstian G. [1 ]
Fuerer, Cristophe [2 ]
Iggo, Richard [1 ]
机构：
[1] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland
[2] ISREC, Epalinges, Switzerland
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.716
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
640
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [41] RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid
    Morgan, T. M.
    Brown, L. G.
    Pitts, T. E. M.
    Gross, T. S.
    Vessella, R. L.
    Corey, E.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 36 - 37
  • [42] Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma
    Xu, Zi-Zhen
    Wang, Wen-Fang
    Fu, Wan-Bin
    Wang, Ai-Hua
    Liu, Zhi-Yin
    Chen, Li-Yun
    Guo, Pei
    Li, Jun-Min
    LEUKEMIA & LYMPHOMA, 2014, 55 (05) : 1151 - 1157
  • [43] RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid
    Morgan, Todd M.
    Pitts, Tiffany E. M.
    Gross, Ted S.
    Poliachik, Sandra L.
    Vessella, Robert L.
    Corey, Eva
    PROSTATE, 2008, 68 (08): : 861 - 871
  • [44] Combination of carboplatin and the mTor inhibitor RAD001 is a new therapeutic approach for p53-mutated breast cancer
    Lin, H.
    Possinger, K.
    Eucker, J.
    CANCER RESEARCH, 2009, 69 (02) : 93S - 93S
  • [45] Phase I study of the combination of everolimus (RAD001) with 5FU/LV in patients with refractory solid malignancies
    Davies, J. M.
    McRee, A. J.
    Sanoff, H. K.
    Triglianos, T.
    Keller, K.
    Ivanova, A.
    Bernard, S. A.
    Goldberg, R. M.
    Dees, E. C.
    O'Neil, B. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [46] Oncolytic Adenovirus Expressing Decorin, Rad.Dcn, Inhibits Lung Metastasis of Breast Cancer in Immune-Competent Mice
    Yang, Yuefeng
    Xu, Weidong
    Zhao, Huiqiang
    Wang, Hao
    Xiao, Fengjun
    Kong, Fanxuan
    Wang, Lisheng
    Wang, Hua
    Seth, Prem
    MOLECULAR THERAPY, 2018, 26 (05) : 343 - 343
  • [47] Delta-24-RGD in combination with RAD001 induces autophagic cell death and 80% long-term survivors
    Alonso, Marta
    Gomez-Manzano, Candelaria
    Jiang, Hong
    Xu, Jing
    Piao, Yuji
    Yokoyama, Tomohisa
    Kondo, Seiji
    Yung, W. K. Alfred
    Fueyo, Juan
    NEURO-ONCOLOGY, 2007, 9 (04) : 491 - 491
  • [48] Phase I/II Study of Everolimus (RAD001) in Combination With Temozolomide (TMZ) in Patients With Advanced Pancreatic Neuroendocrine Tumors (NET)
    Kulke, Matthew H.
    Blaszkowsky, Lawrence
    Zhu, Andrew X.
    Florio, Sarah
    Regan, Eileen
    Ryan, David P.
    Chan, Jennifer A.
    PANCREAS, 2011, 40 (02) : 328 - 328
  • [49] The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo
    Yu, Feng
    Zhao, Jing
    Hu, Yunhui
    Zhou, Yang
    Guo, Rong
    Bai, Jingchao
    Zhang, Sheng
    Zhang, Huilai
    Zhang, Jin
    ONCOLOGY REPORTS, 2016, 36 (01) : 356 - 364
  • [50] Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib
    Dengler, J
    von Bubnoff, N
    Decker, T
    Peschel, C
    Duyster, J
    LEUKEMIA, 2005, 19 (10) : 1835 - 1838
12345